Vasanthi R Sunil Selected Research

Mechlorethamine (Nitrogen Mustard)

3/2024	Role of macrophage bioenergetics in N-acetylcysteine-mediated mitigation of lung injury and oxidative stress induced by nitrogen mustard.
12/2022	Impaired energy metabolism and altered functional activity of alveolar type II epithelial cells following exposure of rats to nitrogen mustard.
1/2020	Lung injury, oxidative stress and fibrosis in mice following exposure to nitrogen mustard.
11/2018	Protective Role of Surfactant Protein-D Against Lung Injury and Oxidative Stress Induced by Nitrogen Mustard.
11/2015	Attenuation of Nitrogen Mustard-Induced Pulmonary Injury and Fibrosis by Anti-Tumor Necrosis Factor-α Antibody.
8/2014	Pentoxifylline attenuates nitrogen mustard-induced acute lung injury, oxidative stress and inflammation.
1/2011	Functional and inflammatory alterations in the lung following exposure of rats to nitrogen mustard.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vasanthi R Sunil Research Topics

Disease

15	Lung Injury 03/2024 - 04/2002
11	Inflammation (Inflammations) 03/2024 - 10/2010
5	Fibrosis (Cirrhosis) 12/2022 - 11/2015
4	Acute Lung Injury 12/2022 - 08/2014
4	Edema (Dropsy) 10/2021 - 06/2013
4	Endotoxemia 10/2007 - 01/2002
3	Poisoning 01/2016 - 02/2011
2	Pneumonia (Pneumonitis) 01/2023 - 04/2015
2	Lung Diseases (Lung Disease) 01/2016 - 01/2011
2	Wounds and Injuries (Trauma) 08/2014 - 09/2012
2	Bronchiolitis 06/2013 - 01/2011
1	Hemorrhage 03/2024
1	Hyperplasia 11/2018
1	Bronchiectasis 11/2018
1	Hypertrophy 11/2018
1	Emphysema 11/2015
1	Pathologic Constriction (Stenosis) 02/2011
1	Bronchiolitis Obliterans 02/2011
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2011
1	Bronchitis 02/2011

Drug/Important Bio-Agent (IBA)

10	Irritants (Vesicants)IBA 12/2022 - 01/2011
7	Mechlorethamine (Nitrogen Mustard)FDA Link 03/2024 - 01/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 10/2010
4	Mustard Gas (Sulfur Mustard)IBA 10/2021 - 02/2011
4	OzoneIBA 04/2015 - 08/2010
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2011
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 05/2012 - 10/2010
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2011 - 04/2002
2	FibrinIBA 03/2024 - 11/2015
2	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 03/2024 - 08/2014
2	CytokinesIBA 01/2023 - 01/2016
2	Galectin 3 (LGALS3)IBA 04/2015 - 09/2012
2	Protein CIBA 08/2014 - 09/2012
2	Surface-Active Agents (Surfactants)IBA 08/2014 - 09/2012
2	LipocalinsIBA 08/2014 - 10/2007
2	2-chloroethyl ethyl sulfideIBA 05/2012 - 02/2011
2	Reactive Nitrogen SpeciesIBA 05/2012 - 08/2010
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2011 - 10/2010
2	LipopolysaccharidesIBA 10/2007 - 01/2002
2	NF-kappa B (NF-kB)IBA 10/2007 - 03/2002
1	N-(3-pyridylmethyl)adriamycin (YM 1)IBA 03/2024
1	Acetylcysteine (Siran)FDA LinkGeneric 03/2024
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	AerosolsIBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	Nylons (Nylon)IBA 01/2023
1	Blood Proteins (Serum Proteins)IBA 10/2021
1	Fibrinogen (Factor I)FDA Link 10/2021
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2018
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 11/2018
1	NitrogenIBA 01/2016
1	Oxygen (Dioxygen)IBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	Alkylating AgentsIBA 11/2015
1	LectinsIBA 04/2015
1	Pentoxifylline (Trental)FDA LinkGeneric 08/2014
1	Matrix Metalloproteinases (MMPs)IBA 08/2014
1	AntigensIBA 08/2014
1	UteroglobinIBA 06/2013
1	CaspasesIBA 02/2011
1	Type I Tumor Necrosis Factor ReceptorsIBA 02/2011
1	Biomarkers (Surrogate Marker)IBA 02/2011
1	DNA Repair EnzymesIBA 02/2011
1	Connective Tissue Growth FactorIBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 10/2007
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2007
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2002
1	EicosanoidsIBA 04/2002

Therapy/Procedure

4	Therapeutics 11/2018 - 01/2011